Mérieux acquires Utah firm Dyad Labs
Dyad Labs began as the in house laboratory of contract manufacturer VMI Nutrition. When VMI was acquired and renamed Genysis, Dyad was spun off as a separate company.
Pioneering protein methods
Prior to 2018 Dyad had pioneered some protein analysis techniques that were adopted at official AOAC methods, according to then vice president Spencer Carter.
According to the Mérieux statement, Dyad now occupies more than 20,000 square feet at its Salt Lake City facility, with six separate lab spaces. Dyad had relocated to the space in 2018 as a result of growth in demand for the company’s services.
"We are enthusiastic about having the talented team at Dyad Labs join us and welcome them to our network of laboratories," said Sébastien Moulard, President of Mérieux NutriSciences, North America. "This acquisition supports our position as a major player in the dietary supplement market and strengthens our presence in the United States."
"Dyad's expertise in supplement testing for active lifestyle brand manufacturers combined with Mérieux NutriSciences' dedication to protecting consumers' health throughout the world will deliver a wide range of solutions to the food and nutrition industries," stated Jeff Reynolds, Founder of Dyad Labs. "This will allow us to expand our services and expertise to better support our customers’ needs and enable their growth, while providing meaningful opportunities for Dyad team members.”
Terms of the deal were not announced.
Trend toward consolidation
The acquisition is part of an ongoing trend toward lab consolidation. Both Eurofins and Lab Corp/Covance have embarked on lab acquisition sprees in North America, and more recently private equity firm Warburg Pincus has joined that development.